Literature DB >> 7673254

Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor.

M Miura1, E Surmacz, J L Burgaud, R Baserga.   

Abstract

The wild type insulin-like growth factor I (IGF-I) receptor has both mitogenic and transforming activities. We have examined the effect of point mutations at tyrosine residues 1250 and 1251 on these two properties of the receptor. For this purpose, we stably transfected plasmids expressing mutant and wild type receptors into R- cells, which are 3T3-like cells, derived from mouse embryos with a targeted disruption of the IGF-I receptor genes, and therefore devoid of endogenous IGF-I receptors. A tyrosine to phenylalanine mutation of either the 1250 or 1251 residue, or both, has no effect on the ability of the receptor to transmit a mitogenic signal. However, the tyrosine 1251 mutant receptor and the double mutant have lost the ability to transform R- cells (colony formation in soft agar), even when the receptors are expressed at very high levels, while the Y1250F mutant is fully transforming. These experiments show that the 1251 tyrosine residue is required for the transforming activity of the IGF-I receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673254     DOI: 10.1074/jbc.270.38.22639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.

Authors:  Alaide Morcavallo; Marco Genua; Angela Palummo; Emilia Kletvikova; Jiri Jiracek; Andrzej M Brzozowski; Renato V Iozzo; Antonino Belfiore; Andrea Morrione
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

2.  Decorin differentially modulates the activity of insulin receptor isoform A ligands.

Authors:  Alaide Morcavallo; Simone Buraschi; Shi-Qiong Xu; Antonino Belfiore; Liliana Schaefer; Renato V Iozzo; Andrea Morrione
Journal:  Matrix Biol       Date:  2014-01-02       Impact factor: 11.583

3.  Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor.

Authors:  D C Stylianou; A Auf der Maur; D P Kodack; R T Henke; S Hohn; J A Toretsky; A T Riegel; A Wellstein
Journal:  Oncogene       Date:  2009-07-27       Impact factor: 9.867

4.  Grb10, a positive, stimulatory signaling adapter in platelet-derived growth factor BB-, insulin-like growth factor I-, and insulin-mediated mitogenesis.

Authors:  J Wang; H Dai; N Yousaf; M Moussaif; Y Deng; A Boufelliga; O R Swamy; M E Leone; H Riedel
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

5.  Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation.

Authors:  W Li; Y X Jiang; J Zhang; L Soon; L Flechner; V Kapoor; J H Pierce; L H Wang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

6.  Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells.

Authors:  C Huang; W Y Ma; Z Dong
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

7.  14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor.

Authors:  R W Furlanetto; B R Dey; W Lopaczynski; S P Nissley
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

8.  Insulin-like growth factor II stimulates cell proliferation through the insulin receptor.

Authors:  A Morrione; B Valentinis; S Q Xu; G Yumet; A Louvi; A Efstratiadis; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

9.  IGF1R inhibition in mammary epithelia promotes canonical Wnt signaling and Wnt1-driven tumors.

Authors:  Lauren M Rota; Lidia Albanito; Marcus E Shin; Corey L Goyeneche; Sain Shushanov; Emily J Gallagher; Derek LeRoith; Deborah A Lazzarino; Teresa L Wood
Journal:  Cancer Res       Date:  2014-08-04       Impact factor: 12.701

10.  Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme.

Authors:  Javier R Revollo; Antje Körner; Kathryn F Mills; Akiko Satoh; Tao Wang; Antje Garten; Biplab Dasgupta; Yo Sasaki; Cynthia Wolberger; R Reid Townsend; Jeffrey Milbrandt; Wieland Kiess; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2007-11       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.